PRNewswire/ — Medivir AB (Nasdaq Stockholm: MVIR) announced today that Medivir AB (‘Medivir’ or ‘the Company’) has …
Medivir strengthens its business development possibilities through a renegotiated agreement with TetraLogic regarding birinapant
Medivir strengthens its business development possibilities through a renegotiated agreement with TetraLogic regarding birinapant
Leave a reply